Related Experiment Video

Updated: Jun 27, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Costs of prenatal genetic screening

Frank Buckley, Sue J Buckley

    Lancet (London, England)
    |November 26, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    FISH for Pre-implantation Genetic Diagnosis
    07:34

    FISH for Pre-implantation Genetic Diagnosis

    Published on: February 23, 2011

    Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
    09:03

    Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

    Published on: August 25, 2019

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
    09:30

    Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

    Published on: August 17, 2022

    FISH for Pre-implantation Genetic Diagnosis
    07:34

    FISH for Pre-implantation Genetic Diagnosis

    Published on: February 23, 2011

    Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
    09:03

    Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

    Published on: August 25, 2019

    Related Concept Videos

    Genetic Screens02:46

    Genetic Screens

    Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
    Forward genetic screens
    Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

    Articles linked to this work by shared authors, journal, and citation graph.

    Estimation of the number of people with Down syndrome in Latin America and the Caribbean.

    Genetics in medicine : official journal of the American College of Medical Genetics·2026

    Evaluating the rumen microbial community of genetically divergent spring-calving dairy cows grazing grass-only or grass-clover swards at different stages of the grazing season.

    Frontiers in microbiology·2025

    Characterisation of the bacterial and archaeal microbiota in fresh colostrum collected from a single, spring-calving dairy herd.

    PloS one·2025

    Temporal establishment of the colon microbiota in Angus calves from birth to post-weaning.

    PloS one·2025

    Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome.

    American journal of medical genetics. Part A·2025

    Estimation of the number of people with Down syndrome living in Canada.

    Genetics in medicine : official journal of the American College of Medical Genetics·2025

    Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

    Lancet (London, England)·2026

    Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    QTL mapping.

    Genetics·2026

    Genetic Insights Into Retinitis Pigmentosa: A De Novo RPGR Mutation in an Iranian-Azeri Family.

    Case reports in ophthalmological medicine·2026

    Altered thalamo-prefrontal synchrony dynamics during spatial working memory task performance in a SETD1A loss-of-function mouse model of schizophrenia predisposition.

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

    Newborn screening and biobanking for preventable genetic disorders in Mongolia: A developing country perspective.

    Regenerative therapy·2026

    Whole-genome resequencing with multidimensional annotation revealed pathogenic networks in sirenomelia.

    Italian journal of pediatrics·2026

    Human Loss-of-Function ZNRF3 Mutation Impairs Adipose Thermogenesis and Drives Subcutaneous Fat Expansion.

    Diabetes·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us